Male Hypogonadism | Treatment Algorithms | Claims Data Analysis | US | 2017
| MARKET OUTLOOKLow testosterone is a condition characterized by impaired spermatogenesis and low serum testosterone. In adult men, low testosterone can be caused by intrinsic abnormalities in the testes or changes in pituitary or hypothalamic upstream signaling pathways contributing to testosterone biosynthesis. Age and comborbidity (e.g., obesity or T2D) driven declines in testosterone levels represent the majority of cases of low testosterone in adult men. TRT, which aims to increase overall serum testosterone levels, is the cornerstone therapy for low testosterone and is primarily administered via injection or topical means. However, a key drawback of TRTs is decreased spermatogenesis, and some alternative therapies for low testosterone focus on the stimulation of gonadotropins in effort to preserve fertility. Additionally, the FDA has recently cautioned against the use of TRT due to the possibility of increased cardiac risk, and this study will evaluate potential changes to physician prescribing and treatment strategies through real-world data analyses.QUESTIONS ANSWERED What patient share do key drug classes garner by line of therapy in newly diagnosed low testosterone patients? How have topical TRTs, injectable TRTs, and other miscellaneous TRT formulations been integrated into the treatment algorithm? What proportion of low testosterone patients receive drug therapy within a year of diagnosis, and how quickly? What percentage of patients progress to later lines of therapy within a year of diagnosis? What are the drug class-level compliance and persistency rates among drug-treated patients with low testosterone?PRODUCT DESCRIPTION Treatment Algorithms: Claims Data Analysis: provides detailed analysis of brand usage across different lines of therapy using real-world data patient-level claims data so you can accurately assess your source of business and quantify areas of opportunity for increasing your brand share. |
Related Market Assessment Reports
Report
Psoriatic Arthritis – Current Treatment – Treatment Algorithms: Claims Data Analysis – Psoriatic Arthritis (US)
Treatment of psoriatic arthritis (PsA) typically begins with conventional DMARDs, such as methotrexate, and progresses to more-potent biologics and/or targeted oral therapies as needed. The U.S…
Report
Atopic Dermatitis / Atopic Eczema – Access & Reimbursement – Access & Reimbursement – Atopic Dermatitis (US)
The treatment landscape for AD in the United States is evolving rapidly. Since 2017, the FDA has approved multiple agents, including systemic and topical JAK inhibitors, nonsteroidal topical…
Report
Painful Diabetic Neuropathy – Current Treatment – Treatment Algorithms: Claims Data Analysis – Painful Diabetic Neuropathy (US)
Painful diabetic neuropathy (PDN) is characterized by numbness, tingling, and burning, sharp, shooting, or other painful sensations, commonly in the feet, legs, and/or hands. PDN is managed with…
